Wayne V S, Harper R W, Laufer E, Federman J, Anderson S T, Pitt A
Aust N Z J Med. 1982 Aug;12(4):285-9. doi: 10.1111/j.1445-5994.1982.tb03813.x.
Three patients with ischaemic heart disease developed profound cardiac failure, hypotension and bradycardia during combined therapy with verapamil and beta-adrenergic blocking drugs. This clinical picture resolved completely with cessation of the combined therapy. Baseline left ventricular function, assessed by cardiac catheterisation or nuclear angiography, was normal in two patients and only mildly reduced in the other. Simultaneously administration of beta-adrenergic blocking drugs and verapamil may result in profound adverse interactions and should only be administered with great caution.
三名缺血性心脏病患者在维拉帕米与β-肾上腺素能阻滞剂联合治疗期间出现严重心力衰竭、低血压和心动过缓。联合治疗停止后,这种临床症状完全缓解。通过心导管检查或核素血管造影评估,两名患者的基线左心室功能正常,另一名患者仅轻度降低。同时使用β-肾上腺素能阻滞剂和维拉帕米可能会导致严重的不良相互作用,应极其谨慎使用。